ANTIHYPERTENSIVE AGENTS - PowerPoint PPT Presentation

1 / 15
About This Presentation
Title:

ANTIHYPERTENSIVE AGENTS

Description:

Describe the impact and mechanisms involved in essential ... Drugs: hydralazine, diazoxide, sodium nitroprusside, minoxidil, enalapril, lisinopril, losartan ... – PowerPoint PPT presentation

Number of Views:794
Avg rating:3.0/5.0
Slides: 16
Provided by: janicei
Category:

less

Transcript and Presenter's Notes

Title: ANTIHYPERTENSIVE AGENTS


1
ANTIHYPERTENSIVE AGENTS
  • Philip J. Kadowitz, Ph.D.

2
Learning Objectives
  • Describe the impact and mechanisms involved in
    essential hypertension.
  • Explain actions of major classes of
    antihypertensive drugs.
  • Describe the use of drugs in the treatment of
    essential hypertension and of a hypertensive
    emergency or crisis.
  • Drugs hydralazine, diazoxide, sodium
    nitroprusside, minoxidil, enalapril,
    lisinopril, losartan

3
Drugs Used in the Treatment of Hypertension
  • Diuretics
  • a. Thiazide diuretics important for
    antihypertensive therapy
  • ? do not exert their effect simply by
    lowering plasma volume
  • ? plasma volume returns to pre-treatment
    levels, but antihypertensive effect
    persists
  • ? alter arteriolar tone
  • b. Potassium-sparing diuretics spironolactone,
    eplerenone, amiloride, triamterene.
  • c. Loop diuretics (e.g., furosemide) used for
    edema reduction decrease plasma volume thereby
    lowering pressure. Use with low GFR.

4
2. Centrally-acting antihypertensive agents
alpha-2 agonists
  • Clonidine (Catapress) acts direclty on
    alpha-2 receptors in vasomotor center
  • Methyldopa (Aldomet - metabolized in CNS to
    ?-methyl norepinephrine, which acts on
    ?2-receptors in vasomotor center
  • 3. Adrenergic receptor-blocking agents
  • a. ?-blockers propranolol, metoprolol,
    atenolol, etc., act on the heart to decrease
    heart rate and stroke volume also more slowly
    to reduce TPR
  • b. ? -blockers
  • Prazosin (Minipress) blocks ? 1 receptors,
    thereby permitting norepinephrine to act on ?
    2 receptors and inhibit release
  • Non-selective ? -blockers rarely used, due
    to reflex tachycardia (phentolamine)

5
4. Adrenergic terminal-blocking drugs
  • Reserpine depletes adarenergic terminals
  • Guanethidine reserpine-like and
    bretylium-like effects of guanethidine deplete
    adrenergic terminals of norepinephrine and
    inhibit transmitter release, thereby reducing
    sympathetic tone to vessels and heart
  • MAO inhibitors (e.g., tranylcypromine,
    phenelzine, pargyline ) not used
  • 5. Direct vasodilators
  • a. Arteriolar
  • Hydralazine always used with ?-blocker due
    to reflex tachycardia and with a diuretic
  • Diazoxide chemically related to thiazide
    diuretics used in hypertensive crisis
  • Minoxidil used in hypertensive patients
    refractory to other agents grows hair

6
b. Arteriolar and venous
  • Nitroprusside (Nipride) - used only i.v. in
    hypertensive crisis can titrate blood pressure
    to desired level with infusion (rapid onset,
    rapid termination of action)
  • 6. Calcium entry blockers
  • L-type calcium channel blockers
  • 7. Renin-angiotensin inhibitors
  • a. ACE inhibitors
  • ? peptidyl dipeptidase (converting enzyme)
    inhibitors
  • ? inhibit formation of angiotensin II
    (active) from angiotensin I (inactive)
  • ? inhibit breakdown of bradykinin
  • ? effective orally
  • ? cause coughing in up to 25 of patients

7
Captopril
  • ? short-acting
  • ? not a prodrug
  • Enalapril
  • ? prodrug long-acting
  • b. Angiotensin receptor antagonists ARBS
    effective orally, do not alter bradykinin
    levels
  • Losartan
  • Candesartan
  • Valsartan

8
Major Drugs
  • ? Diuretics
  • ? Beta-blockers
  • ? Calcium entry blockers
  • ? ACE inhibitors
  • ? ARBS

9
New approach to treatment of hypertension
  • ? Allhat trial
  • ? JNC 7 and 8

10
Figure 11-1. Anatomic sites of blood pressure
control.
11
Figure 11-2. Baroreceptor reflex arc.
12
Figure 11-3. Sites of action of the major
classes of antihypertensive drugs.
13
Figure 11-4. Guanethidine actions and drug
interactions involving the adrenergic neuron. (G,
guanethidine NE, norepinephrine TCA, tricyclic
antidepressants.)
14
Figure 11-6. Sites of action of ACE inhibitors
and angiotensin II receptor blockers. 1 Site of
ACE blockade. 2 Site of receptor blockade.
15
Figure 314. Summary of the three major effects
of angiotensin II and the mechanisms that mediate
them.
Write a Comment
User Comments (0)
About PowerShow.com